View Cart (0 items)


Cytokinetics cuts work force, ends cancer research

September 17, 2008
The Associated Press reports that Biotechnology company Cytokinetics Inc. has announced it will slash its work force by 29 percent and end research activities on potential cancer treatments as part
Read More

King Pharmaceuticals launches hostile bid for Alpharma

September 12, 2008
Drug developer King Pharmaceuticals Inc. launched its tender offer for rival Alpharma Inc., taking its offer directly to shareholders after raising its bid 12 percent to $1.6 billion, as reported
Read More

ImClone receives another buyout offer

September 10, 2008
Biotechnology company ImClone Systems Inc., reported that it has received an offer from a large pharmaceuticals company to buy the company for $70 a share in cash, according to Reuters.
Read More

NC judge awards $57.5 million to Durham drug company

September 5, 2008
A Wake County judge has awarded more than $57 million to a Durham drug development company after finding that a former Serenex employee, chemist Yunsheng Huang, stole experimental cancer formulas
Read More

Pfizer wins Lipitor patent dispute in Denmark

August 29, 2008
Pfizer Inc. said Friday a court in Denmark has blocked Ranbaxy Laboratories from launching a generic version of the blockbuster cholesterol drug Lipitor in that country. Pfizer said a court
Read More

Jobs fall one percent in New Jersey pharmaceutical industry

August 18, 2008
The Associated Press reports that layoffs and restructurings are taking a toll on drug and medical technology companies in New Jersey, one of the state''s most important industries. A survey
Read More

Merck spent nearly $1.2 million lobbying government in second quarter

August 13, 2008
The Associated Press reports that drugmaker Merck & Co. Inc. spent nearly $1.2 million lobbying on pharmaceutical issues in the second quarter, according to a recent disclosure form. Merck lobbied
Read More

Pfizer biotech unit plans San Francisco relocation

August 11, 2008
The Associated Press reports that Pfizer Inc. will relocate its biotech research center to San Francisco. The company plans to move the unit in early 2010 from its current location
Read More

Abbott faces more litigation over AIDS drug

August 4, 2008
When Abbott Laboratories Inc. hiked up the price of a popular AIDS drug by 400 percent in 2003, executives prepared for the inevitable public relations hit, according to the Associated
Read More

Sanofi to buy UK vaccine maker Acambis

July 28, 2008
Sanofi-Aventis SA said its planned 276 million pound ($551 million) acquisition of Acambis PLC will bolster its leading position in the vaccine market and strengthen its development pipeline, according to
Read More